Skip to main navigation Skip to search Skip to main content

Yeast particle encapsulation of scaffolded terpene compounds for controlled terpene release

  • Ernesto R. Soto
  • , Florentina Rus
  • , Hanchen Li
  • , Carli Garceau
  • , Jeffrey Chicca
  • , Mostafa Elfawal
  • , David Gazzola
  • , Martin K. Nielsen
  • , Joseph F. Urban
  • , Raffi V. Aroian
  • , Gary R. Ostroff

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Terpenes are naturally occurring compounds produced by plants that are of great commercial interest in the food, agricultural, cosmetic, and pharmaceutical industries due to their broad spectra of antibacterial, antifungal, anthelmintic, membrane permeation enhancement, and antioxi-dant biological activities. Applications of terpenes are often limited by their volatility and the need for surfactants or alcohols to produce stable, soluble (non-precipitated) products. Yeast particles (YPs) are hollow, porous microspheres that have been used for the encapsulation of terpenes (YP terpenes) by passive diffusion of terpenes through the porous YP cell walls. We here report the development of a second generation YP encapsulated terpene technology that incorporates the stimuli-responsive control of terpene release using biodegradable pro-terpene compounds (YP pro-terpenes). YP terpenes and YP pro-terpenes were both produced, in which high levels of carvacrol, eugenol, thymol and geraniol were encapsulated. The YP pro-terpenes show higher encapsulation stability than YP terpenes due to pro-terpenes being non-volatile solids at room temperature and stable in suspensions at neutral pH. YP pro-terpenes and YP terpenes were evaluated for biological activity in antibacterial, antifungal and anthelmintic assays. The YP pro-terpenes retained the full biological activity of the parent terpene compound.

Original languageEnglish
Article number1207
JournalFoods
Volume10
Issue number6
DOIs
StatePublished - 2021

Bibliographical note

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Funding

Funding: This research was funded by (1) the National Institutes of Health/National Institute of Allergy and Infectious Diseases grants R01AI056189 and R01AI50866 to R.V.A., (2) Agriculture and Food Research Initiative Competitive Grant no. 2015–11323 from the USDA National Institute of Food and Agriculture to R.V.A., and (3) Sponsored Research Agreement from Eden Research plc to G.R.O.

FundersFunder number
Eden Research plc
National Institutes of Health (NIH)
National Institute of Allergy and Infectious F32-AI286447 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R01AI168214 Jason W. Rosch Diseases National Institute of Allergy and Infectious P30 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R00-AI166116 Christopher D. Radka Diseases National Institute of Allergy and Infectious T32-AI106700 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R01AI192221 Jason W. Rosch Diseases National Inst...R01AI056189, 2015–11323, R01AI50866
US Department of Agriculture National Institute of Food and Agriculture, Agriculture and Food Research Initiative

    Keywords

    • Anthelmintic
    • Antimicrobial
    • Prodrug
    • Terpenes
    • Yeast particles

    ASJC Scopus subject areas

    • Food Science
    • Microbiology
    • Health(social science)
    • Health Professions (miscellaneous)
    • Plant Science

    Fingerprint

    Dive into the research topics of 'Yeast particle encapsulation of scaffolded terpene compounds for controlled terpene release'. Together they form a unique fingerprint.

    Cite this